- Company Overview for GLAXOSMITHKLINE LIMITED (12215835)
- Filing history for GLAXOSMITHKLINE LIMITED (12215835)
- People for GLAXOSMITHKLINE LIMITED (12215835)
- More for GLAXOSMITHKLINE LIMITED (12215835)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
13 Sep 2023 | CS01 | Confirmation statement made on 13 September 2023 with no updates | |
16 Aug 2023 | PSC06 | Change of details for Glaxo Group Limited as a person with significant control on 6 June 2023 | |
11 Jul 2023 | AA | Accounts for a dormant company made up to 31 December 2022 | |
23 Sep 2022 | CS01 | Confirmation statement made on 13 September 2022 with no updates | |
16 May 2022 | CERTNM |
Company name changed gsk LIMITED\certificate issued on 16/05/22
|
|
16 May 2022 | CONNOT | Change of name notice | |
18 Feb 2022 | AA | Accounts for a dormant company made up to 31 December 2021 | |
13 Sep 2021 | CS01 | Confirmation statement made on 13 September 2021 with no updates | |
19 Jul 2021 | AA | Audit exemption subsidiary accounts made up to 31 December 2020 | |
20 May 2021 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/20 | |
20 May 2021 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/20 | |
20 May 2021 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/20 | |
11 May 2021 | AP02 | Appointment of Edinburgh Pharmaceutical Industries Limited as a director on 6 May 2021 | |
13 Nov 2020 | CS01 | Confirmation statement made on 18 September 2020 with no updates | |
02 Oct 2019 | AA01 | Current accounting period extended from 30 September 2020 to 31 December 2020 | |
25 Sep 2019 | RESOLUTIONS |
Resolutions
|
|
25 Sep 2019 | CONNOT | Change of name notice | |
19 Sep 2019 | NEWINC |
Incorporation
Statement of capital on 2019-09-19
|